Clinical Trial: THCV Lowers Blood Sugar Levels In Type 2 Diabetics

medical marijuana

UNITED KINGDOM: The administration of THCV (tetrahydrocannabivarin), a non-psychoactive component of cannabis, is positively associated with glycemic control in type 2 diabetics, according to the randomized, placebo-controlled data published in the journal Diabetes Care. Investigators from the University of Nottingham, School of Medicine assessed the twice daily administration of various cannabinoids (CBD or THCV or CBD and THCV in Read the full article…